Dr. PingLi

Dr. Ping Li focuses her practice on biotechnological, pharmaceutical, and chemical patents involving nanoparticle and macromolecule drugs, small molecule antiviral and anticancer therapies, polymer technology, chemical engineering, and paper technology. In addition to patent drafting, prosecution, opposition, and appeal proceedings, Ping has particular experience in matters relating to supplementary protection certificates (SPCs) including assisting and advising clients on obtaining SPCs and creating SPC portfolios in Europe. She also has experience in IP due diligence, freedom-to-operate analysis, and patent validity opinion and has been involved in German as well as cross-border patent infringement and revocation proceedings. Ping joined Jones Day in May 2008.

Ping is a chemist and a structural biologist by training with technical experience in organic and inorganic synthesis, NMR (nuclear magnetic resonance) spectroscopy, molecular biology, protein crystallography, protein expression and purification, RNA (ribonucleic acid) biochemistry, virology, antibody, chromatography, mass spectroscopy, electron microscopy, and radioactive labeling. Her doctoral work at the Max Planck Institute for Biophysical Chemistry led to several peer-reviewed publications including a first author publication in the journal Science in 2007. Ping's scientific background allows her to quickly grasp the essence of inventions relating to a broad spectrum of technological fields.

Ping is a member of the Institute of Professional Representatives before the European Patent Office (epi), the German Patent Bar Association, the International Federation of Intellectual Property Attorneys, and the German Association for the Protection of Intellectual Property (GRUR).